Cooley-Led Vaxcyte Prices $750M Public Offering
By Yeji Jesse Lee · January 31, 2024, 7:53 PM EST
Public vaccine developer Vaxcyte has priced a $750 million public offering of common stock and pre-funded warrants, represented by Cooley LLP, the company has announced....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login